A compound red coat blood tonifying pharmaceutical preparation and its application and detection method
The technology of a pharmaceutical preparation and red clothing is applied in the field of compound red clothing blood-enriching pharmaceutical preparations, which can solve the problems of complex process, high price, insignificant effect and the like, and achieves the effects of broad application prospect, low cost, remarkable and reliable curative effect and the like.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0028] A compound red coat blood tonifying drug preparation, which is prepared from the following raw materials in weight ratio:
[0029] 60 parts of peanut red coat, 50 parts of jujube, 50 parts of astragalus, 50 parts of Eclipta, 40 parts of Polygonum multiflorum,
[0030] 40 parts of cinnamon, 40 parts of mulberry fruit, 40 parts of Ligustrum lucidum, 40 parts of raspberry, 40 parts of Atractylodes macrocephala,
[0031] 40 parts of papaya, 35 parts of licorice, 35 parts of poria cocos, 35 parts of dandelion, 35 parts of Sijiqing,
[0032] 30 parts of frankincense, 30 parts of green skin, 30 parts of comfrey, 30 parts of jujube seed, 30 parts of myrrh,
[0033] Guizhi 20 parts, Salvia miltiorrhiza 20 parts, Morinda officinalis 20 parts, Lycium barbarum 20 parts, Albizia juniper bark 20 parts, Coix seed 20 parts.
[0034] The preparation method of described pharmaceutical preparation is as follows:
[0035] Take by weighing above-mentioned crude drug according to above-me...
Embodiment 2
[0041] Toxicity test:
[0042]In this experiment, healthy SD rats were used, and the dosage gradient of the drug prepared in Example 1 was administered orally at 0.01g / kg and 0.1g / kg, and the drug was administered continuously for 30 days. Animal growth status, activity diet, hematology, blood biochemistry, organ tissue structure and urine routine were not significantly affected, indicating that the clinical medication is safe and reliable.
Embodiment 3
[0044] Summary of clinical efficacy:
[0045] General information, the pharmaceutical preparation of the present invention is applied to 108 cases of clinical observation, and all subjects are divided into 2 groups on average, control group and experimental group, each group of 54 people, two groups of cases are statistically analyzed in terms of gender, age, course of disease, etc. Analysis is comparable.
[0046] The diagnostic criteria formulated by WHO in 1972 considered that anemia was diagnosed when Hb was lower than the following levels in sea level areas: 110g / L for children aged 6 months to <6 years, 120g / L for children aged 6-14, 130g / L for adult males, and 130g / L for adults. 120g / L for women and 110g / L for pregnant women. It should be noted that the normal hemoglobin value of residents living in plateau areas is higher than that of sea-level residents; during pregnancy, hypoalbuminemia, congestive heart failure, splenomegaly, and macroglobulinemia, plasma volume in...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com